TIRZEPATIDE 5mg - The Diabetes Killer

Trizepatide, a breakthrough in diabetes management, is a unique dual  glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like  peptide-1 agonist (GLP-1). This innovative compound has garnered  attention for its superior performance in glycemic control and weight  management when compared to selective GLP-1 receptor agonists, as  demonstrated in both preclinical and clinical trials. Derived from the protein sequence of endogenous GIP, Trzepatide”™s  pharmacological action on GLP-1 receptors mirrors that of natural GIP.  It serves multifaceted roles as a glucagon-like peptide-1 receptor  agonist, an anti-obesity agent, a hypoglycemic agent, a gastric  inhibitory polypeptide receptor agonist, and an incretin mimetic. Reconstitution: To utilize Trizepatide effectively, the 5 mg dosage should be  reconstituted with bacteriostatic water (BAC), ensuring optimal  stability and efficacy. Note: Products are for laboratory research use only. Not for human use consumption.